Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth
暂无分享,去创建一个
M. Daudon | J. Dagorn | Y. Berland | B. Dussol | R. Boistelle | P. Dupuy | P. Berthézène | J. Verdier | P. Casanova | P. Dupuy | B. DUSSOL | P. BERTHEZENE | Y. BERLAND | J. C. DAGORN
[1] F. Coe,et al. Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. , 1990, Kidney international.
[2] J. Dagorn,et al. Renaming pancreatic stone protein as 'lithostathine'. , 1990, Gastroenterology.
[3] R. Rege,et al. Isolation of an acidic protein from cholesterol gallstones, which inhibits the precipitation of calcium carbonate in vitro. , 1989, The Journal of clinical investigation.
[4] F. Coe,et al. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. , 1989, The American journal of physiology.
[5] J. Dagorn,et al. Secretory pancreatic stone protein messenger RNA. Nucleotide sequence and expression in chronic calcifying pancreatitis. , 1989, The Journal of clinical investigation.
[6] H. Sarles,et al. Complete amino acid sequence of an immunoreactive form of human pancreatic stone protein isolated from pancreatic juice. , 1987, European journal of biochemistry.
[7] Y. Nakagawa,et al. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. , 1987, The Journal of clinical investigation.
[8] R. Scott,et al. Prevalence of calcified upper urinary tract stone disease in a random population survey. Report of a combined study of general practitioners and hospital staff. , 1987, British journal of urology.
[9] H. Sarles,et al. Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein. , 1986, The Biochemical journal.
[10] H. Sarles,et al. Immunocytochemical Localization of Pancreatic Stone Protein in the Human Digestive Tract , 1986, Pancreas.
[11] C. Figarella. Pancreatic stone protein , 1985, Digestive diseases and sciences.
[12] D. Lombardo,et al. Pancreatic stone protein. II. Implication in stone formation during the course of chronic calcifying pancreatitis. , 1985, Gastroenterology.
[13] D. Lombardo,et al. The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth. , 1984, The Biochemical journal.
[14] E. Kaiser,et al. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. , 1983, The Journal of biological chemistry.
[15] D. Lombardo,et al. Pancreatic stone protein, a phosphoprotein which inhibits calcium carbonate precipitation from human pancreatic juice. , 1983, Biochemical and biophysical research communications.
[16] F. Oppenheim,et al. Phosphoproteins in the parotid saliva from the subhuman primate Macaca fascicularis. Isolation and characterization of a proline-rich phosphoglycoprotein and the complete covalent structure of a proline-rich phosphopeptide. , 1982, The Journal of biological chemistry.
[17] W. N. Burnette,et al. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. , 1981, Analytical biochemistry.
[18] H. Sarles,et al. Characterization of a protein isolated from pancreatic calculi of men suffering from chronic calcifying pancreatitis. , 1979, Biochemical and biophysical research communications.
[19] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[20] F. Carone,et al. Contraluminal serum albumin uptake in isolated perfused renal tubules. , 1973, The American journal of physiology.
[21] J. Schnermann,et al. The effect of luminal application of colloids on rat proximal tubular net fluid flux. , 1972, Kidney international.
[22] E. Bresler. Aspects of tubular reabsorption revisited. , 1970, Chest.
[23] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[24] H. Fleisch,et al. Isolation from urine of pyrophosphate, a calcification inhibitor. , 1962, The American journal of physiology.
[25] R. Ryall,et al. The Effect of Macromolecules on the Crystallization of Calcium Oxalate in Human Urine , 1989 .
[26] J. Sallis. Glycosaminoglycans as inhibitors of stone formation. , 1987, Mineral and electrolyte metabolism.
[27] Sallis Jd. Glycosaminoglycans as inhibitors of stone formation. , 1987 .
[28] B. Ulshöfer. Epidemiological Aspects of Urolithiasis in a German County , 1985 .
[29] W. Robertson,et al. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.
[30] C. Tisher,et al. Morphology of the ascending thick limb of Henle. , 1976, Kidney international.